...A. Today, we reported strong second quarter results of 9% operational growth in revenue and 12% operational growth in adjusted net income based on our diverse portfolio across markets and species. B. As expected, we returned to a more balanced segment growth this quarter with 11% operational growth internationally and 7% growth in the U.S. C. Our companion animal portfolio grew 11% operationally, driven by our major franchises in dermatology, osteoarthritis pain and pet parasiticides. D. The second quarter results and drivers were more in line with our performance trends in recent years with innovations and strength in our companion animal portfolio leading the way. E. Meanwhile, our livestock portfolio grew 4% operationally in the second quarter, driven by sales of poultry, cattle and fish products, and continue to demonstrate the benefits of our diversified portfolio across species and geographies with a strong first half. F. We have grown revenue 6% operationally in the first half, driven...